Nerve growth factor eye drop administration improves visual function in a patient with optic glioma

Neurorehabilitation and Neural Repair

Volumn 25, Issue 4, 2011, Pages 386-390

  Chiaretti, Antonio ^a   Falsini, Benedetto ^a   Servidei, Serenella ^a   Marangoni, Dario ^a   Pierri, Filomena ^a   Riccardi, Riccardo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Nerve growth factor; Neuroprotection; Optic gliomas; Vision loss

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CHOLINERGIC STIMULATION; COLOR VISION DEFECT; COLOR VISION TEST; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; EXOPHTHALMOS; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE ATROPHY; OPTIC NERVE GLIOMA; SPECTROPHOTOMETRY; VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; WILCOXON SIGNED RANKS TEST;

FEMALE; HUMANS; MIDDLE AGED; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENTS; OPHTHALMIC SOLUTIONS; OPTIC NERVE GLIOMA; RECOVERY OF FUNCTION; VISION, LOW;

EID: 79954577280     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968310395601     Document Type: Article

References (32)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987;874:1154-1162. (Pubitemid 17124912)
2. DeKosky ST, Taffe KM, Abrahamson EE, Dixon CE, Kochanek PM, Ikonomovic MD. Time course analysis of hippocampal nerve growth factor and antioxidant enzyme activity following lateral controlled cortical impact brain injury in the rat. J Neurotrauma. 2004;21:491-500. (Pubitemid 38656747)
3. Chiaretti A, Barone G, Riccardi R, et al. NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children. Neurology. 2009;72:609-616.
4. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol. 1999;57:451-484. (Pubitemid 29057112)
5. Eriksdotter Jönhagen M, Nordberg A, Amberla K, et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 1998;9:246-257. (Pubitemid 28377225)
6. Olson L, Backlund EO, Ebendal T, et al. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch Neurol. 1991;48:373-381.
7. Chiaretti A, Antonelli A, Genovese O, et al. Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic-ischemic brain injury. Neurol Res. 2008;30:223-228. (Pubitemid 351769412)
8. Chiaretti A, Genovese O, Riccardi R, et al. Intraventricular nerve growth factor infusion: a possible treatment for neurological deficits following hypoxic-ischemic brain injury in infants. Neurol Res. 2005;27:741-746. (Pubitemid 41513083)
9. Micera A, Lambiase A, Aloe L, Bonini S, Levi-Schaffer F, Bonini S. Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev. 2004;15:411-417. (Pubitemid 39550452)
10. Carmignoto G, Comelli MC, Candeo P, et al. Expression of NGF receptor mRNA in the developing and adult rat retina. Exp Neurobiol. 1991;111:302-311.
11. Caleo M, Menna E, Chierzi S, Cenni MC, Maffei L. Brainderived neurotrophic factor is an anterograde survival factor in the rat visual system. Curr Biol. 2000;10:1155-1161.
12. Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci. 1989;9:1263-1272. (Pubitemid 19116746)
13. Siliprandi R, Canella R, Carmignoto G. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci. 1993;34:3232-3245. (Pubitemid 23346655)
14. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med. 1998;338:1174-1180. (Pubitemid 28180745)
15. Lambiase A, Aloe L, Centofanti M, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc Natl Acad Sci U S A. 2009;106:13469-13474.
16. Lambiase A, Tirassa P, Micera A, Aloe L, Bonini S. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci. 2005;46:3800-3806. (Pubitemid 44264689)
17. Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30, 000 molecular weight protein. Proc Natl Acad Sci U S A. 1969;64:787-794.
18. Stifter E, König F, Lang T, et al. Reliability of a standardized reading chart system: variance component analysis, test-retest and inter-chart reliability. Graefes Arch Clin Exp Ophthalmol. 2004;242:31-39. (Pubitemid 38208282)
19. Ross DF, Fishman GA, Gilbert LD, Anderson RJ. Variability of visual field measurements in normal subjects and patients with retinitis pigmentosa. Arch Ophthalmol. 1984;102:1004-1010. (Pubitemid 14083479)
20. Falsini B, Ziccardi L, Lazzareschi I, et al. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J Neurooncol. 2008;88:87-96.
21. Coassin M, Lambiase A, Sposato V, Micera A, Bonini S, Aloe L. Retinal p75 and bax over expression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefes Arch Clin Exp Ophthalmol. 2008;246:1743-1749.
22. Lambiase A, Centofanti M, Micera A, et al. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 1997;235:780-785. (Pubitemid 27514275)
23. Pizzorusso T, Porciatti V, Tseng JL, Aebischer P, Maffei L. Transplant of polymered capsulated cells genetically engineered to release nerve growth factor allows a normal functional development of the visual cortex in dark-reared rats. Neuroscience. 1997;80:307-311. (Pubitemid 27334582)
24. Rohrer B, Korenbrot JI, LaVail MM, Reichardt LF, Xu B. Role of neurotrophin receptor TrkB in the maturation of rod photoreceptors and establishment of synaptic transmission to the inner retina. J Neurosci. 1999;19:8919-8930. (Pubitemid 30226713)
25. Lu B. Acute and long-term synaptic modulation by neurotrophins. Prog Brain Res. 2004;146:137-150. (Pubitemid 37541381)
26. Sofroniew MV, Howe CL, Moblley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001;24:1217-1281. (Pubitemid 32695259)
27. Chen H, Weber AJ. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci. 2001;42:966-974. (Pubitemid 32289791)
28. Brown MC, Staniszewska I, Lazarovici P, Tuszynski GP, Del Valle L, Marcinkiewicz C. Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. Neuro Oncol. 2008;10:968-980.
29. Li JT, Yan Q, Yu HL. Expression of VEGF and NGF in gliomas of human. Sichuan Xue Xue Bao Yi Xue Ban. 2009;40: 408-411.
30. Chiaretti A, Aloe L, Antonelli A, et al. Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas. Childs Nerv Syst. 2004;20:412-419. (Pubitemid 38997078)
31. Kimura S, Yoshino A, Katayama Y, Watanabe T, Fukushima T. Growth control of C6 glioma in vivo by nerve growth factor. J Neurooncol. 2002;59:199-205. (Pubitemid 35021569)
32. Hegedus B, Hughes FW, Garbow JR, et al. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma. J Neuropathol Exp Neurol. 2009;68:542-551.